COPD

Business

Sanofi and Regeneron’s Dupixent set for large gains with likely COPD approval

IvelinRadkov Sanofi (NASDAQ:SNY) and Regeneron Pharmaeuticals (NASDAQ:REGN) Dupixent (dupiliumab), already a blockbuster drug approved for several indications, including asthma and…

Read More »
Science

COPD: Inhalable nanoparticles could help treat chronic lung disease

Chronic obstructive pulmonary disease affects the lungs SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY Delivering medication to the lungs with inhalable nanoparticles may…

Read More »
Business

Theravance, Mylan settle patent litigation over COPD drug Yupelri (TBPH)

Olivier Le Moal Theravance (NASDAQ:TBPH) said that it and partner Mylan have granted Teva (NYSE:TEVA) a royalty-free, non-exclusive license to…

Read More »
Back to top button